Hypertension in Pregnancy Clinical Trial
Official title:
Assessment of Patient Education as a Method of Optimizing Postpartum Care in Women With Hypertension
Verified date | March 2022 |
Source | Medstar Health Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a prospective single centered randomized control study for postpartum patients diagnosed with hypertension. Participants that meet inclusion criteria will be approached while they are inpatient. After enrollment, all study subjects will receive an automated blood pressure cuff and instructions on how to use it. Study participants in the intervention group will be provided with educational material. The investigators hypothesize education in postpartum women with hypertension can improve patient compliance with attendance at postpartum care appointments.
Status | Completed |
Enrollment | 46 |
Est. completion date | December 15, 2021 |
Est. primary completion date | June 25, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Postpartum with diagnosis of Hypertension is defined as chronic hypertension, gestational hypertension, preeclampsia without severe features, preeclampsia with severe features, chronic hypertension with superimposed preeclampsia with and without severe features. - At least 18 years or older - English speaking patient and also able to read in English - Plan to receive postpartum care at Washington Hospital Center Exclusion Criteria: - Women who do not intend to follow up at Washington Hospital Center - Suffered from intrauterine fetal demise |
Country | Name | City | State |
---|---|---|---|
United States | MedStar Washington Hospital Center | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
Medstar Health Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compliance with postpartum care | The investigators will perform a retrospective chart review to determine if the study participant attended the postpartum BP check appointment | This outcome will be evaluated within 10 days of discharge | |
Primary | Compliance with postpartum care | The investigators will perform a retrospective chart review to determine if the study participant attended the postpartum BP check appointment | This outcome will be evaluated within 6 weeks of delivery | |
Secondary | Incidence of postpartum re-admission for hypertension related concerns | The investigators will retrospectively review if the study participants are re-admitted for hypertension related concerns | This outcome will be evaluated within 6 weeks of delivery | |
Secondary | Incidence of postpartum labor and delivery triage visits | The investigators will retrospectively review if the study participants are evaluated in the labor and delivery triage for hypertension related concerns | This outcome will be evaluated within 6 weeks of delivery | |
Secondary | Incidence of postpartum emergency department visits | The investigators will retrospectively review if the study participants are evaluated in the emergency department for hypertension related concerns | This outcome will be evaluated within 6 weeks of delivery | |
Secondary | Evaluate weight (kg) change | The investigators will retrospectively compare the participants weight upon delivery admission to weight upon discharge and within 6 weeks of delivery | This outcome will be evaluated upon hospital admission | |
Secondary | Evaluate weight (kg) change | The investigators will retrospectively compare the participants weight upon delivery admission to weight upon discharge and within 6 weeks of delivery | This outcome will be evaluated upon hospital discharge | |
Secondary | Evaluate weight (kg) change | The investigators will retrospectively compare the participants weight upon delivery admission to weight upon discharge and within 6 weeks of delivery | This outcome will be evaluated within 6 week after delivery | |
Secondary | Incidence of stroke | The investigators will retrospectively review if the study participant suffered a stroke | This outcome will be evaluated within 6 weeks of delivery | |
Secondary | Incidence of maternal death | The investigators will retrospectively review maternal death during this study period | This outcome will be evaluated within 6 weeks of delivery | |
Secondary | Participant satisfaction with postpartum education using likert scale | A likert scale survey will be administered by the investigator to the intervention and control group, the satisfaction score will be compared between both groups. The scale is reported as follows: 1 (Strongly disagree) 2 3 (neutral) 4 5 (strongly agree). | This outcome will be evaluated at time of recruitment, within 48hours | |
Secondary | Participant satisfaction with postpartum education | A survey will be administered by the investigator to the intervention and control group, the satisfaction score will be compared between both groups. The responses are either Yes or No. For most questions, answering yes would be a favorable response. | This outcome will be evaluated at time of recruitment, within 48hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00974714 -
L-arginine Effects on Chronic Hypertension in Pregnancy
|
Phase 3 | |
Terminated |
NCT03595982 -
Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily?
|
Phase 4 | |
Completed |
NCT03506724 -
Response to Anti-hypertensives in Pregnant and Postpartum Patients
|
Phase 4 | |
Completed |
NCT03613714 -
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT04604535 -
The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy
|
N/A | |
Completed |
NCT00412230 -
Insulin Resistance and Hypertensive Disorders in Pregnancy
|
N/A | |
Active, not recruiting |
NCT05049616 -
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
|
Phase 4 | |
Completed |
NCT04119232 -
Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy
|
N/A | |
Completed |
NCT04633551 -
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
|
N/A | |
Completed |
NCT05859282 -
Development and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced Hypertension
|
||
Active, not recruiting |
NCT05543265 -
Bridging the Gap From Postpartum to Primary Care
|
N/A | |
Completed |
NCT00571766 -
Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy
|
Phase 3 | |
Recruiting |
NCT05473767 -
Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children
|
N/A | |
Recruiting |
NCT05683093 -
Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
|
||
Completed |
NCT06403722 -
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
|
||
Recruiting |
NCT05852054 -
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
|
Phase 3 | |
Recruiting |
NCT05137808 -
Understanding Blood Pressure Changes After Birth
|
||
Completed |
NCT03961360 -
Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03648645 -
Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure
|
N/A | |
Recruiting |
NCT06054841 -
Reshaping Postpartum Follow-up
|
N/A |